Addiction Center (all authors) and Michigan Innovations in Addiction Care Through Research and Education (Coughlin), Department of Psychiatry, University of Michigan, Ann Arbor; Center for Clinical Management Research, Ann Arbor Veterans Affairs (VA) Healthcare System, Ann Arbor (Ilgen)
Auto-generated profile, based on publicly available information
Mark A. Ilgen
Addiction Center (all authors) and Michigan Innovations in Addiction Care Through Research and Education (Coughlin), Department of Psychiatry, University of Michigan, Ann Arbor; Center for Clinical Management Research, Ann Arbor Veterans Affairs (VA) Healthcare System, Ann Arbor (Ilgen)
Management of chronic pain is one of the most common reasons given by individuals seeking medical cannabis. However, very little information exists about the concurrent use of cannabis and prescription pain medication (PPM). This study fills this gap in knowledge by systematically comparing medical cannabis users who use or do not use PPM, with an emphasis on understanding whether concurrent use of cannabis and PPM is associated with more serious forms of alcohol and other drug involvement. Data from this study were collected from a medical cannabis clinic in southwestern Michigan (N = 273). Systematic comparisons were made on measures of sociodemographics, reasons for substance use, pain, functioning, and perceptions of PPM and medical cannabis efficacy. PPM users tended to be older and reported higher levels of pain and lower levels of functioning. The overall sample exhibited higher lifetime and past-3-month rates of alcohol and other noncannabis drug use than did the general population. Approximately 40% of subjects reported combining cannabis with alcohol, but no significant difference was observed between PPM users and nonusers. PPM users and nonusers did not exhibit any difference in either lifetime or past-3-month use of other drugs, including cocaine, sedatives, street opioids, and amphetamines. PPM users rated the efficacy of cannabis higher than PPM for pain management and indicated a strong desire to reduce PPM usage. Use of PPM among medical cannabis users was not identified as a correlate for more serious forms of alcohol and other drug involvement. However, longitudinal study designs are needed to better understand the trajectories of alcohol and other drug involvement over time among medical cannabis users.
Reducing suicide risk among active duty soldiers and Veterans is a national priority. Because substance use disorders (SUDs) are key risk factors for both fatal and non-fatal suicidal behaviors, SUD treatment program staff are in frequent contact with high-risk individuals. However, no data exist on the efficacy of suicide-specific interventions conducted in SUD Treatment. The proposed research study addresses this gap by testing the efficacy of a targeted intervention designed to reduce suicide risk in Veterans treated for SUDs. The primary objective of this study is to evaluate the impact of a Cognitive Behavioral Therapy (CBT) intervention compared to a Supportive Psycho-education Control (SPC) condition on subsequent suicidal thoughts and behaviors in Veterans with SUDs. During this research period, project staff have been refining study materials and measures, hiring key project staff, and submitting applications to various regulatory boards for approval to prepare for subject recruitment.